Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 143,004 | 142,895 | 110,780 | 91,767 | 78,871 |
| Operating Income | -143,004 | -142,895 | -110,780 | -91,767 | -78,871 |
| Other Income | 13,536 | 15,048 | 10,083 | 2,645 | 156 |
| Pre-tax Income | -129,468 | -127,847 | -100,697 | -89,122 | -78,715 |
| Net Income Continuous | -129,468 | -127,847 | -100,697 | -89,122 | -78,715 |
| Net Income | $-129,468 | $-127,847 | $-100,697 | $-89,122 | $-78,715 |
| EPS Basic Total Ops | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 |
| EPS Basic Continuous Ops | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 |
| EPS Diluted Total Ops | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 |
| EPS Diluted Continuous Ops | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.83 | -1.96 | -2.25 | -2.07 |
| EBITDA(a) | $-144,084 | $-149,891 | $-115,917 | $-91,843 | $-76,625 |